[
  {
    "date": "2023-12-30",
    "symbol": "NVCT",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-41264",
    "entityregistrantname": "NUVECTIS PHARMA, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "86-2405608",
    "entityaddressaddressline1": "1 Bridge Plaza",
    "entityaddressaddressline2": "Suite 275",
    "entityaddresscityortown": "Fort Lee",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7024,
    "cityareacode": 201,
    "localphonenumber": "614-3150",
    "security12btitle": "Common Stock, par value $0.00001 per",
    "tradingsymbol": "NVCT",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1875558,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "PricewaterhouseCoopers International Limited",
    "auditorlocation": "Tel-Aviv, Israel",
    "auditorfirmid": 1309,
    "cashandcashequivalentsatcarryingvalue": 19126000,
    "otherassetscurrent": 59000,
    "assetscurrent": 19185000,
    "assets": 19185000,
    "accountspayablecurrent": 2771000,
    "accruedliabilitiescurrent": 415000,
    "employeerelatedliabilitiescurrent": 3798000,
    "liabilitiescurrent": 6984000,
    "liabilities": 6984000,
    "additionalpaidincapital": 66446000,
    "retainedearningsaccumulateddeficit": -54245000,
    "stockholdersequity": 12201000,
    "liabilitiesandstockholdersequity": 19185000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 17418886,
    "commonstocksharesoutstanding": 17418886,
    "researchanddevelopmentexpense": 15380000,
    "generalandadministrativeexpense": 7517000,
    "operatingincomeloss": -22897000,
    "financeincome": 637000,
    "netincomeloss": -22260000,
    "netincomelossavailabletocommonstockholdersbasic": -22260000,
    "earningspersharebasic": -1.43,
    "earningspersharediluted": -1.43,
    "weightedaveragenumberofsharesoutstandingbasic": 15556655,
    "weightedaveragenumberofdilutedsharesoutstanding": 15556655,
    "sharesoutstanding": 17418886,
    "stockissuedduringperiodvaluenewissues": 5114000,
    "stockissuedduringperiodsharesnewissues": 371743,
    "adjustmenttoadditionalpaidincapitalconvertibledebtinstrumentissuedatsubstantialpremium": 4705000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 663499,
    "stockissuedduringperiodvaluewarrantsexercised": 8906000,
    "stockissuedduringperiodshareswarrantsexercised": 1001091,
    "stockissuedduringperiodvaluestockoptionsexercised": 38000,
    "stockissuedduringperiodsharesstockoptionsexercised": 6809,
    "offeringcosts": 174000,
    "offeringcostonexerciseofpreferredinvestmentoptions": 755000,
    "profitloss": -22260000,
    "sharebasedcompensation": 4705000,
    "increasedecreaseinothercurrentassets": -353000,
    "increasedecreaseinaccountspayable": -139000,
    "increasedecreaseinaccruedliabilities": -30000,
    "increasedecreaseinaccruedcompensationandbenefits": 1417000,
    "netcashprovidedbyusedinoperatingactivities": -15954000,
    "proceedsfromissuanceofcommonstock": 5289000,
    "paymentsofstockissuancecosts": 174000,
    "paymentsofstockissuancecostsrelatedtoinitialpublicoffering": 341000,
    "proceedsfromwarrantexercises": 11192000,
    "paymentsofissuancecostsforwarrantexerciseandpreferredinvestmentoption": 371000,
    "paymentsofstockissuancecostsrelatedtoprivateplacement": 508000,
    "netcashprovidedbyusedinfinancingactivities": 15087000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -867000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 19126000,
    "numberofoperatingsegments": 1,
    "shareprice": 14.23,
    "saleofstockconsiderationreceivedontransaction": 5100000,
    "operatingleasecost": 14000,
    "moneymarketfundsatcarryingvalue": 17100000,
    "researchanddevelopmentlaborandrelatedexpense": 6310000,
    "clinicalexpense": 4296000,
    "licensefees": 1001000,
    "manufacturingcosts": 3495000,
    "researchanddevelopmentprofessionalfee": 278000,
    "professionalfees": 3460000,
    "laborandrelatedexpense": 2298000,
    "generalinsuranceexpense": 842000,
    "travelexpenses": 369000,
    "othergeneralandadministrativeexpense": 548000,
    "projectcost": 600000,
    "collaborativearrangementthresholdpaymentsrelatedtofuturefundraising": 3000000,
    "milestoneachievementexpensespaid": 1000000,
    "privateplacementexpenses": 400000,
    "collaborativeagreementamountutilizedfromfundraisingcommitment": 800000,
    "commonstockvotingright": 1,
    "numberofpreferredinvestmentoptionsexercised": 1001091,
    "proceedsfromexerciseofpreferredinvestmentoptions": 8900000,
    "numberofwarrantsexercised": 79104,
    "grossproceedsfromissuanceofcommonstock": 5300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 43500,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 21000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedfairvalue": 74000,
    "numberofplacementagentwarrantsexercised": 79104,
    "warrantexercised": 105920,
    "proceedsfromwarrantexercise": 700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentoffullydilutedsharesissuableuponvesting": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardthresholdtradingdays": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardthresholdaveragecapitalization": 350000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y7M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 300000,
    "conversionofstocksharesissued1": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 348281,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 60810,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 348281,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.59,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 8.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y11M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1317000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1317000,
    "allocatedsharebasedcompensationexpense": 2100000,
    "weightedaveragenumberofsharesissuedbasic": 16691708,
    "weightedaveragenumberofsharesrestrictedstock": 1135053,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 159870,
    "effectiveincometaxratecontinuingoperations": 0.269,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.059,
    "operatinglosscarryforwards": 35000000,
    "effectiveincometaxratereconciliationotheradjustments": -0.05,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.22,
    "deferredtaxassetsoperatinglosscarryforwards": 9625000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2236000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 52000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 2578000,
    "deferredtaxassetsgross": 14491000,
    "deferredtaxassetsvaluationallowance": 14491000,
    "deferredtaxassetvaluationallowanceadditions": 5918000
  }
]